{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:44:47Z","timestamp":1790869487021,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.asjsur.2023.12.119","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T07:29:01Z","timestamp":1703834941000},"page":"1383-1388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1168-3161","authenticated-orcid":false,"given":"Kentaro","family":"Iwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Yoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ogiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.asjsur.2023.12.119_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.asjsur.2023.12.119_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jhbp.314","article-title":"Biliary tract cancer registry in Japan from 2008 to 2013","volume":"23","author":"Ishihara","year":"2016","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"10272","key":"10.1016\/j.asjsur.2023.12.119_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.asjsur.2023.12.119_bib4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (Prodige 12-accord 18-Unicancer GI): a randomized phase III study","volume":"10","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.asjsur.2023.12.119_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.asjsur.2023.12.119_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"1","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10372","key":"10.1016\/j.asjsur.2023.12.119_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.asjsur.2023.12.119_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.asjsur.2023.12.119_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s41669-020-00221-y","article-title":"Real-world evidence: bridging gaps in evidence to guide payer decisions","volume":"5","author":"Roberts","year":"2021","journal-title":"Pharmacoecon Open"},{"issue":"3","key":"10.1016\/j.asjsur.2023.12.119_bib10","first-page":"147","article-title":"Real-world studies: bridging the gap between trial-assessed efficacy and routine care","volume":"36","author":"Chen","year":"2022","journal-title":"J\u00a0Biomed Res"},{"issue":"2","key":"10.1016\/j.asjsur.2023.12.119_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hpb.2019.07.008","article-title":"Completion of adjuvant therapy in patients with resected pancreatic cancer","volume":"22","author":"DePeralta","year":"2020","journal-title":"HPB (Oxford)"},{"issue":"10","key":"10.1016\/j.asjsur.2023.12.119_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00595-020-01995-8","article-title":"Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists","volume":"50","author":"Kano","year":"2020","journal-title":"Surg Today"},{"issue":"2","key":"10.1016\/j.asjsur.2023.12.119_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.asjsur.2023.12.119_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10147-013-0578-x","article-title":"A\u00a0single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer","volume":"19","author":"Yamanaka","year":"2014","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.asjsur.2023.12.119_bib15","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.21873\/anticanres.13329","article-title":"The efficacy and limitations of postoperative adjuvant chemotherapy in patients with extrahepatic cholangiocarcinoma","volume":"39","author":"Morino","year":"2019","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.asjsur.2023.12.119_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/SLA.0000000000003851","article-title":"Oncological resection for liver malignancies can the laparoscopic approach provide benefits?","volume":"275","author":"Yoh","year":"2022","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.asjsur.2023.12.119_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jhbp.552","article-title":"Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"25","author":"Yoh","year":"2018","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"2","key":"10.1016\/j.asjsur.2023.12.119_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/SLA.0000000000002865","article-title":"A\u00a0prospective, randomized phase II study of adjuvant gemcitabine versus S-1 after major hepatectomy for biliary tract cancer (KHBO 1208): kansai hepato-biliary oncology group","volume":"270","author":"Kobayashi","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.asjsur.2023.12.119_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3892\/mco.2015.500","article-title":"Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest","volume":"3","author":"Yamatsuji","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.asjsur.2023.12.119_bib20","series-title":"TNM Classification of Malignant Tumours","year":"2016"},{"issue":"3","key":"10.1016\/j.asjsur.2023.12.119_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.sla.0000201482.11876.14","article-title":"Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up","volume":"243","author":"Nagino","year":"2006","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.asjsur.2023.12.119_bib22","first-page":"464","article-title":"Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer","volume":"6","author":"Kawazoe","year":"2015","journal-title":"J\u00a0Cancer"},{"issue":"18","key":"10.1016\/j.asjsur.2023.12.119_bib23","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"10041","key":"10.1016\/j.asjsur.2023.12.119_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"16","author":"Uesaka","year":"2016","journal-title":"Lancet"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958423020833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958423020833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:31:36Z","timestamp":1760895096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958423020833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1015958423020833"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2023.12.119","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2023.12.119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}